Lyka Labs Limited
NSE: LYKALABS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kunal Narendra Gandhi
- Employees
- 423
- Headquarters
- Mumbai, India
- IPO year
- 1996
- Market cap
- ₹2.3B
- Website
- https://www.lykalabs.com
Loading LYKALABS…
Loading profile data…Frequently asked questions about LYKALABS
What does Lyka Labs Limited (LYKALABS.NS) do?
Lyka Labs Limited, a pharmaceutical company, engages in development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial,...
Where does LYKALABS.NS trade?
Lyka Labs Limited (LYKALABS.NS) trades on the National Stock Exchange of India.
What sector is LYKALABS.NS in?
Lyka Labs Limited (LYKALABS.NS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lyka Labs Limited?
Kunal Narendra Gandhi is the chief executive officer of Lyka Labs Limited (LYKALABS.NS).
Where is Lyka Labs Limited headquartered?
Lyka Labs Limited is headquartered in India.
Does LYKALABS.NS pay a dividend?
Lyka Labs Limited (LYKALABS.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LYKALABS.NS go public?
Lyka Labs Limited (LYKALABS.NS) completed its initial public offering in 1996.